Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
45
GROV Quote, Financials, Valuation and Earnings
Last price:
$1.36
Seasonality move
:
5.82%
Day range:
$1.46 - $1.55
52-week range:
$1.19 - $1.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.27x
P/B ratio:
42.98x
Volume:
78.9K
Avg. volume:
85.3K
1-year change:
-11.38%
Market cap:
$59.4M
Revenue:
$203.4M
EPS (TTM):
-$0.76
Analysts' Opinion
-
Consensus RatingGrove Collaborative Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.50, Grove Collaborative Holdings has an estimated upside of 68.92% from its current price of $1.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $1.48.
Fair Value
-
According to the consensus of 2 analysts, Grove Collaborative Holdings has 68.92% upside to fair value with a price target of $2.50 per share.
GROV vs. S&P 500
-
Over the past 5 trading days, Grove Collaborative Holdings has underperformed the S&P 500 by -6.16% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Grove Collaborative Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Grove Collaborative Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Grove Collaborative Holdings reported revenues of $49.5M.
Earnings Growth
-
Grove Collaborative Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Grove Collaborative Holdings reported earnings per share of -$0.34.
Enterprise value:
72.1M
EV / Invested capital:
3.04x
Price / LTM sales:
0.27x
EV / EBIT:
--
EV / Revenue:
0.35x
PEG ratio (5yr expected):
-0.15x
EV / Free cash flow:
-6.26x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$109.3M
Return On Assets:
-23.22%
Net Income Margin (TTM):
-13.48%
Return On Equity:
-154.22%
Return On Invested Capital:
-39.61%
Operating Margin:
-16.83%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $321.5M | $259.3M | $203.4M | $59.9M | $49.5M | |
| Gross Profit | $154.7M | $137.4M | $109.3M | $32.6M | $25.9M | |
| Operating Income | -$141M | -$35.3M | -$22.5M | -$7.9M | -$8.3M | |
| EBITDA | -$72.3M | -$21.3M | -$4.8M | -$3.9M | -$8.6M | |
| Diluted EPS | -$6.92 | -$1.29 | -$0.76 | -$0.27 | -$0.34 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $140.9M | $142M | $124.2M | $44.9M | |
| Total Assets | -- | $182.5M | $174M | $150.7M | $65M | |
| Current Liabilities | -- | $69.2M | $57.5M | $35M | $27.1M | |
| Total Liabilities | -- | $150.8M | $147.5M | $132.6M | $48.8M | |
| Total Equity | -- | $31.6M | $26.5M | $18.1M | $16.2M | |
| Total Debt | -- | $66.9M | $61.2M | $71.7M | $7.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$96.3M | -$8M | -$9.7M | $1.1M | $270K | |
| Cash From Investing | -$4.2M | -$3M | -$1.6M | -$602K | -$322K | |
| Cash From Financing | $118.1M | $9.9M | -$59.2M | -$390K | -$31.2M | |
| Free Cash Flow | -$100.5M | -$11M | -$11.5M | $507K | -$95K | |
GROV
Sector
Market Cap
$59.4M
$412.6M
Price % of 52-Week High
75.9%
70.4%
Dividend Yield
0%
0%
Shareholder Yield
--
3.85%
1-Year Price Total Return
-11.38%
-15%
Beta (5-Year)
--
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.56
200-day SMA
Buy
Level
$1.46
Bollinger Bands (100)
Sell
Level
1.35 - 1.61
Chaikin Money Flow
Sell
Level
-26.4M
20-day SMA
Sell
Level
$1.61
Relative Strength Index (RSI14)
Sell
Level
35.74
ADX Line
Sell
Level
14.79
Williams %R
Buy
Level
-92.3077
50-day SMA
Sell
Level
$1.55
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
76.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-10.2634)
Sell
CA Score
(Annual)
Level (-1.8989)
Buy
Beneish M-Score
(Annual)
Level (-4.5499)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.4998)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
Stock Forecast FAQ
In the current month, GROV has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GROV average analyst price target in the past 3 months is $2.50.
-
Where Will Grove Collaborative Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Grove Collaborative Holdings share price will rise to $2.50 per share over the next 12 months.
-
What Do Analysts Say About Grove Collaborative Holdings?
Analysts are divided on their view about Grove Collaborative Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Grove Collaborative Holdings is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is Grove Collaborative Holdings's Price Target?
The price target for Grove Collaborative Holdings over the next 1-year time period is forecast to be $2.50 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GROV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Grove Collaborative Holdings is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GROV?
You can purchase shares of Grove Collaborative Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Grove Collaborative Holdings shares.
-
What Is The Grove Collaborative Holdings Share Price Today?
Grove Collaborative Holdings was last trading at $1.36 per share. This represents the most recent stock quote for Grove Collaborative Holdings. Yesterday, Grove Collaborative Holdings closed at $1.48 per share.
-
How To Buy Grove Collaborative Holdings Stock Online?
In order to purchase Grove Collaborative Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
